Literature DB >> 33674989

Systemic sclerosis is associated with lower limb vascular stiffness and microvascular impairment: results from a prospective study.

Charles Cassius1,2,3, Vannina Seta4, Jean-Benoit Monfort5, Nathalie Abdoucheli Baudot5, Sébastien Rivière6, Arsène Mekinian6, Camille Frances5, Annick Barbaud5, Patricia Senet5.   

Abstract

OBJECTIVE: Systemic sclerosis (SSc) is a connective tissue disease characterized by microangiopathy. Peripheral arterial disease, increasingly studied during SSc, is responsible for digital ulcers, associated with a high risk of amputation. The aim of our study was to assess the frequency of lower limb arterial impairment in SSc patients by measuring ankle-brachial index (ABI), toe pressure (TP), and toe-brachial index (TBI).
METHODS: Systemic sclerosis patients were included prospectively during 1 year in Tenon and Saint-Antoine Hospitals, Paris. Clinical and biological data were recorded. For each patient, ABI, TP, and TBI were measured and an arterial duplex ultrasonography was prescribed in case of abnormal results.
RESULTS: Eighty-six patients were included (94% women, median age 62 years). Only 24% of them had no lower limb hemodynamic vascular abnormalities; 44% had an isolated microvascular abnormality (normal ABI and TBI<0.75); 31% had at least a macrovascular injury associated or not with microvascular impairment (abnormal ABI) and 12.6% had a TP<50 mmHg. During follow-up, there was a trend towards association of low TBI with more major adverse event (all-cause mortality, non-fatal stroke, non-fatal myocardial infarction, and lower limb ischemic manifestations) than normal TBI.
CONCLUSION: By measuring ABI and TP, we showed that 76% of SSc patients had hemodynamic arterial lower limb abnormalities related to macro- and/or microvascular impairment and that 28% had vascular stiffness. In SSc patients, ABI is not an accurate tool to detect lower limb arterial disease, likely due to underlying micro- and macrovascular changes. Key Points • The presence of lower limb macro-and/or microvascular involvement was detected in 76% of SSc patients. • In SSc patients, ABI is not an accurate tool to detect lower limb arterial disease, likely due to underlying microvascular changes and frequent arterial stiffness.

Entities:  

Keywords:  Ankle-brachial index; Microangiopathy; Peripheral arterial disease; Systemic sclerosis; Toe-brachial index; Vascular stiffness

Year:  2021        PMID: 33674989     DOI: 10.1007/s10067-021-05672-0

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  8 in total

1.  2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

Authors:  Frank van den Hoogen; Dinesh Khanna; Jaap Fransen; Sindhu R Johnson; Murray Baron; Alan Tyndall; Marco Matucci-Cerinic; Raymond P Naden; Thomas A Medsger; Patricia E Carreira; Gabriela Riemekasten; Philip J Clements; Christopher P Denton; Oliver Distler; Yannick Allanore; Daniel E Furst; Armando Gabrielli; Maureen D Mayes; Jacob M van Laar; James R Seibold; Laszlo Czirjak; Virginia D Steen; Murat Inanc; Otylia Kowal-Bielecka; Ulf Müller-Ladner; Gabriele Valentini; Douglas J Veale; Madelon C Vonk; Ulrich A Walker; Lorinda Chung; David H Collier; Mary Ellen Csuka; Barri J Fessler; Serena Guiducci; Ariane Herrick; Vivien M Hsu; Sergio Jimenez; Bashar Kahaleh; Peter A Merkel; Stanislav Sierakowski; Richard M Silver; Robert W Simms; John Varga; Janet E Pope
Journal:  Arthritis Rheum       Date:  2013-10-03

2.  Circulating levels of Nepsilon-(carboxymethyl)lysine are increased in systemic sclerosis.

Authors:  O Kaloudi; G Basta; F Perfetto; F Bartoli; A Del Rosso; I Miniati; M L Conforti; S Generini; S Guiducci; R Abbate; A Pignone; S Castellani; R Livi; R De Caterina; M Matucci-Cerinic
Journal:  Rheumatology (Oxford)       Date:  2006-08-27       Impact factor: 7.580

3.  Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis.

Authors:  F Bartoli; C Angotti; C Fatini; M L Conforti; S Guiducci; J Blagojevic; D Melchiorre; G Fiori; S Generini; N Damjanov; S Rednic; A Pignone; S Castellani; R Abbate; M Matucci Cerinic
Journal:  Rheumatology (Oxford)       Date:  2007-01-30       Impact factor: 7.580

4.  An evaluation of the efficacy of methods used in screening for lower-limb arterial disease in diabetes.

Authors:  Dean T Williams; Keith G Harding; Patricia Price
Journal:  Diabetes Care       Date:  2005-09       Impact factor: 19.112

Review 5.  The toe-brachial index in the diagnosis of peripheral arterial disease.

Authors:  Christian Høyer; Jes Sandermann; Lars J Petersen
Journal:  J Vasc Surg       Date:  2013-05-18       Impact factor: 4.268

6.  An evaluation of the efficacy of the toe brachial index measuring vascular involvement in systemic sclerosis and other connective tissue diseases.

Authors:  Y Muro; K Sugiura; Y Morita; Y Tomita
Journal:  Clin Exp Rheumatol       Date:  2009 May-Jun       Impact factor: 4.473

7.  Lower-limb Ulcers in Systemic Sclerosis: A Multicentre Retrospective Case-control Study.

Authors:  Gérôme Bohelay; Sophie Blaise; Pierre Levy; Antoine Claeys; Nathalie Baudot; Jean-Francois Cuny; Hervé Maillard; Florence Granel-Brocard; Thierry Boyé; Catherine Lok; Nathalie Bénéton; Camille Francès; Patricia Senet
Journal:  Acta Derm Venereol       Date:  2018-07-11       Impact factor: 4.437

Review 8.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Marie D Gerhard-Herman; Heather L Gornik; Coletta Barrett; Neal R Barshes; Matthew A Corriere; Douglas E Drachman; Lee A Fleisher; Francis Gerry R Fowkes; Naomi M Hamburg; Scott Kinlay; Robert Lookstein; Sanjay Misra; Leila Mureebe; Jeffrey W Olin; Rajan A G Patel; Judith G Regensteiner; Andres Schanzer; Mehdi H Shishehbor; Kerry J Stewart; Diane Treat-Jacobson; M Eileen Walsh
Journal:  Circulation       Date:  2016-11-13       Impact factor: 29.690

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.